Description:

Rapid Response® COVID-19 IgG/IgM Rapid Test Device is the first of its kind in Canada and is currently authorized by Health
Canada (Interim Order #313076) for Point-Of-Care Use with fingerstick blood sample. The test device can rapidly & qualitatively test for the presence of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG antibodies in human whole blood, serum, or plasma samples.

Easy to Use:
Bring all testing materials and specimens to
room temperature (18-30°C) before use.
1. Add 1 drop of whole blood.
2. Add 2 drops of the included buer solution.
3. See results in 15 minutes.

PCR Validated Samples
Clinical Study Results Using Fingerstick Blood Samples

*15 Days from Symptom Onset:
IgG Sensitivity – 100%

Combined Sensitivity and Specicity Data:
IgG Sensitivity – 90.5%
IgG Specificity – 100%
*IgG antibodies become detectable 1-3 weeks after infection.
IgM Sensitivity – 88.1%
IgM Specificity – 100%

*Product approved from Health Canada